Pharmaceutical composition and anti-tumor agent for tumor having decreased function of at least one of bap1 or pbrm1
US-2024207301-A1 · Jun 27, 2024 · US
Wages David is listed as an inventor on 7 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Wages David |
| Total patents | 7 |
| First publication | May 20, 2021 |
| Latest publication | Jun 27, 2024 |
Publications ranked by popularity score, then publication date.
US-2024207301-A1 · Jun 27, 2024 · US
US-12006803-B2 · Jun 11, 2024 · US
US-2023050639-A1 · Feb 16, 2023 · US
US-11434704-B2 · Sep 6, 2022 · US
US-2022195817-A1 · Jun 23, 2022 · US
US-2022003094-A1 · Jan 6, 2022 · US
US-2021148206-A1 · May 20, 2021 · US
Latest publications not already listed above.
No data yet.
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Ncs Multistage Inc | 4 |
| Ncs Multistage Llc | 2 |
| Tuttle Elliott | 2 |
| Wages David | 2 |
| Baker Hughes Oilfield Operations Llc | 2 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| E21B43/12 | 6 |
| E21B43/26 | 4 |
| E21B2200/06 | 4 |
| E21B34/14 | 2 |
| E21B43/305 | 2 |